Employers have a great deal of influence when it comes to healthcare in general and the wellbeing of their employee populations. That means there is an abundance of opportunities for those who take that role seriously.
Last week, eight biotech companies went public on Nasdaq, raising a total of $645 million and adding $3.3 billion in market valuation to the sector. This has been another active week, and there are even more biotech IPOs to come.
Last week, AvroBio and Magenta Therapeutics priced their IPOs on the same night. Less than three months earlier, Unum Therapeutics priced its IPO. All three are cell and gene therapy biotechs. The author shares his reflections on those companies, the …
If you were to ask the CEOs of Pfizer, Merck, Lilly, etc., they would be more than happy to drop the “user fees” and have Congress fully fund the FDA via other funding mechanisms.
For many Americans, motivation to exercise at the end of a long and grueling workday is constantly out of reach. New CDC data has now revealed that the share of U.S. adults meeting federal exercise guidelines is alarmingly low.
Green energy milestones in Qinghai, WeChat’s latest feature involving human DNA, and tumor recognition algorithms from Baidu are some of the top tech headlines to emerge from China this week.